Skip to content

Nhân Chứng Giê-hô-va

Chọn ngôn ngữ Việt

Phẫu thuật tim mạch

Xử lý và tối ưu hóa sự cầm máu

Thuốc chống tiêu fibrin

Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation.

Dell'Amore A, Caroli G, Nizar A, Cassanelli N, Luciano G, Greco D, Dolci G, Bini A, Stella F.

Nguồn‎: Heart Lung Circ 2012;21(11):706-10.

Mã bài‎: PubMed 22842057

DOI‎: 10.1016/j.hlc.2012.06.016

https://www.ncbi.nlm.nih.gov/pubmed/22842057

Can local application of tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial.

Fawzy H, Elmistekawy E, Bonneau D, Latter D, Errett L.

Nguồn‎: J Cardiothorac Surg 2009;4:25.

Mã bài‎: PubMed 19538741

DOI‎: 10.1186/1749-8090-4-25

https://www.ncbi.nlm.nih.gov/pubmed/19538741

Current status of pharmacologic therapies in patient blood management.

Goodnough LT, Shander A.

Nguồn‎: Anesth Analg 2013;116(1):15-34.

Mã bài‎: PubMed 23223098

DOI‎: 10.1213/ANE.0b013e318273f4ae

https://www.ncbi.nlm.nih.gov/pubmed/23223098

The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.

Greilich PE, Jessen ME, Satyanarayana N, Whitten CW, Nuttall GA, Beckham JM, Wall MH, Butterworth JF.

Nguồn‎: Anesth Analg 2009;109(1):15-24.

Mã bài‎: PubMed 19535691

DOI‎: 10.1213/ane.0b013e3181a40b5d

https://www.ncbi.nlm.nih.gov/pubmed/19535691

Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin.

Howell N, Senanayake E, Freemantle N, Pagano D.

Nguồn‎: J Thorac Cardiovasc Surg 2013;145(1):234-40.

Mã bài‎: PubMed 22889481

DOI‎: 10.1016/j.jtcvs.2012.07.018

https://www.ncbi.nlm.nih.gov/pubmed/22889481

The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.

Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS.

Nguồn‎: Anesth Analg 2010;110(1):21-9.

Mã bài‎: PubMed 19910626

DOI‎: 10.1213/ANE.0b013e3181c0ea6d

https://www.ncbi.nlm.nih.gov/pubmed/19910626

Comparative evaluation of the effects of tranexamic acid and low-dose aprotinin on post-valvular heart surgery bleeding and allogenic transfusion.

Mansouri M, Attary M, Bagheri K, Massoumi G, Ghavami B.

Nguồn‎: Interact Cardiovasc Thorac Surg 2012;15(1):23-7.

Mã bài‎: PubMed 22514257

DOI‎: 10.1093/icvts/ivs114

https://www.ncbi.nlm.nih.gov/pubmed/22514257

A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting.

Murphy GJ, Mango E, Lucchetti V, Battaglia F, Catapano D, Rogers CA, Angelini GD.

Nguồn‎: J Thorac Cardiovasc Surg 2006;132(3):475-80, 480.e1-8.

Mã bài‎: PubMed 16935098

DOI‎: 10.1016/j.jtcvs.2006.01.064

https://www.ncbi.nlm.nih.gov/pubmed/16935098

Tranexamic acid in patients undergoing coronary-artery surgery.

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network

Nguồn‎: N Engl J Med 2017;376(2):136-48.

Mã bài‎: PubMed 27774838

DOI‎: 10.1056/NEJMoa1606424

http://www.ncbi.nlm.nih.gov/pubmed/27774838

Aprotinin for patients exposed to clopidogrel before off-pump coronary bypass.

Nurözler F, Kutlu T, Küçük G.

Nguồn‎: Asian Cardiovasc Thorac Ann 2008;16(6):483-7.

Mã bài‎: PubMed 18984759

DOI‎: 10.1177/021849230801600611

https://www.ncbi.nlm.nih.gov/pubmed/18984759

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial.

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Nguồn‎: JAMA Surg 2013;148(6):538-47.

Mã bài‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study.

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

Nguồn‎: Anesth Analg 2012;115(2):239-43.

Mã bài‎: PubMed 21737704

DOI‎: 10.1213/ANE.0b013e3182264a11

https://www.ncbi.nlm.nih.gov/pubmed/21737704

Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery.

Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Hu S.

Nguồn‎: Ann Thorac Surg 2010;89(5):1489-95.

Mã bài‎: PubMed 20417766

DOI‎: 10.1016/j.athoracsur.2010.02.006

https://www.ncbi.nlm.nih.gov/pubmed/20417766

Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study.

Øvrum E, Tangen G, Tølløfsrud S, Ringdal MA, Øystese R, Istad R.

Nguồn‎: Interact Cardiovasc Thorac Surg 2010;10(4):545-8.

Mã bài‎: PubMed 20067988

DOI‎: 10.1510/icvts.2009.226613

https://www.ncbi.nlm.nih.gov/pubmed/20067988

Yếu tố đông máu VIIa tái tổ hợp (rFVIIa)

Use of recombinant activated factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.

Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.

Nguồn‎: Transfusion 2013;53(4):798-804.

Mã bài‎: PubMed 22845023

DOI‎: 10.1111/j.1537-2995.2012.03801.x

https://www.ncbi.nlm.nih.gov/pubmed/22845023

Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.

Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.

Nguồn‎: Ann Thorac Surg 2008;85(3):836-44.

Mã bài‎: PubMed 18291152

DOI‎: 10.1016/j.athoracsur.2007.06.076

https://www.ncbi.nlm.nih.gov/pubmed/18291152

Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia.

Elmistekawy E, Lapierre H, Bourke M, Dennie C, Labinaz M, Ruel M.

Nguồn‎: Can J Cardiol 2011;27(6):869.e7-8.

Mã bài‎: PubMed 21983113

DOI‎: 10.1016/j.cjca.2011.07.632

https://www.ncbi.nlm.nih.gov/pubmed/21983113

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery.

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

Nguồn‎: Circulation 2009;120(1):21-7.

Mã bài‎: PubMed 19546387

DOI‎: 10.1161/CIRCULATIONAHA.108.834275

https://www.ncbi.nlm.nih.gov/pubmed/19546387

Intraoperative use of recombinant activated factor VII during complex aortic surgery.

Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.

Nguồn‎: J Thorac Cardiovasc Surg 2012;143(5):1198-204.

Mã bài‎: PubMed 22285329

DOI‎: 10.1016/j.jtcvs.2012.01.004

https://www.ncbi.nlm.nih.gov/pubmed/22285329

Off-label use of recombinant human factor VIIa.

Goodnough LT, Levy JH.

Nguồn‎: Ann Thorac Surg 2014;98(2):393-5.

Mã bài‎: PubMed 25087781

DOI‎: 10.1016/j.athoracsur.2014.06.007

https://www.ncbi.nlm.nih.gov/pubmed/25087781

Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).

Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.

Nguồn‎: Eur J Cardiothorac Surg 2011;40(6):1320-7.

Mã bài‎: PubMed 21550261

DOI‎: 10.1016/j.ejcts.2011.03.032

https://www.ncbi.nlm.nih.gov/pubmed/21550261

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery.

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Nguồn‎: Circulation 2008;118(4):331-8.

Mã bài‎: PubMed 18606914

DOI‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

Nguồn‎: J Vasc Surg 2011;53(4):1032-7.

Mã bài‎: PubMed 21215579

DOI‎: 10.1016/j.jvs.2010.07.075

https://www.ncbi.nlm.nih.gov/pubmed/21215579

Use of activated recombinant factor VII in severe bleeding—evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding.

Lau P, Ong V, Tan WT, Koh PL, Hartman M.

Nguồn‎: Transfus Med Hemother 2012;39(2):139-50.

Mã bài‎: PubMed 22670132

DOI‎: 10.1159/000338034

https://www.ncbi.nlm.nih.gov/pubmed/22670132

Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection.

Lehr EJ, Alford TJ, Wang SH.

Nguồn‎: Heart Surg Forum 2010;13(5):E275-9.

Mã bài‎: PubMed 20961825

DOI‎: 10.1532/HSF98.20101027

https://www.ncbi.nlm.nih.gov/pubmed/20961825

Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes.

Masud F, Bostan F, Chi E, Pass SE, Samir H, Stuebing K, Liebl MG.

Nguồn‎: J Cardiothorac Vasc Anesth 2009;23(1):28-33.

Mã bài‎: PubMed 18948033

DOI‎: 10.1053/j.jvca.2008.08.003

https://www.ncbi.nlm.nih.gov/pubmed/18948033

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery.

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM.

Nguồn‎: Drugs R D 2015;15(2):187-94.

Mã bài‎: PubMed 25862216

DOI‎: 10.1007/s40268-015-0093-9

https://www.ncbi.nlm.nih.gov/pubmed/25862216

Hemostatic management of severe thrombocytopenia in a patient undergoing pulmonic valve replacement.

Tanaka KA, Li P, McHugh SM, Subramaniam K.

Nguồn‎: A A Case Rep 2015;5(1):3-5.

Mã bài‎: PubMed 26125690

DOI‎: 10.1213/XAA.0000000000000166

https://www.ncbi.nlm.nih.gov/pubmed/26125690

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®).

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Nguồn‎: Anesthesiology 2003;98(6):1513-5.

Mã bài‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668

Recombinant activated factor VII in cardiac surgery: a systematic review.

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Nguồn‎: Ann Thorac Surg 2007;83(2):707-14.

Mã bài‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029

Yếu tố đông máu cô đặc

Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion.

Alberts M, Bandarenko N, Gaca J, Lockhart E, Milano C, Alexander S, Linder D, Lombard FW, Welsby IJ.

Nguồn‎: Transfusion 2014;54(5):1348-57.

Mã bài‎: PubMed 24898456

DOI‎: 10.1111/trf.12463

https://www.ncbi.nlm.nih.gov/pubmed/24898456

Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery.

Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F.

Nguồn‎: Interact Cardiovasc Thorac Surg 2012;15(3):382-9.

Mã bài‎: PubMed 22623627

DOI‎: 10.1093/icvts/ivs224

https://www.ncbi.nlm.nih.gov/pubmed/22623627

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient.

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Nguồn‎: Ann Thorac Surg 2009;88(5):1666-8.

Mã bài‎: PubMed 19853132

DOI‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery.

Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C.

Nguồn‎: Crit Care 2016;20:5.

Mã bài‎: PubMed 26738468

DOI‎: 10.1186/s13054-015-1172-6

https://www.ncbi.nlm.nih.gov/pubmed/26738468

State of the art - how I manage coagulopathy in cardiac surgery patients.

Davidson S.

Nguồn‎: Br J Haematol 2014;164(6):779-89.

Mã bài‎: PubMed 24450971

DOI‎: 10.1111/bjh.12746

https://www.ncbi.nlm.nih.gov/pubmed/24450971

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study.

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Nguồn‎: Thromb Haemost 2009;102(1):137-44.

Mã bài‎: PubMed 19572078

DOI‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.

Nguồn‎: J Thorac Cardiovasc Surg 2013;145(3 Suppl):S178-85.

Mã bài‎: PubMed 23410777

DOI‎: 10.1016/j.jtcvs.2012.12.083

https://www.ncbi.nlm.nih.gov/pubmed/23410777

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial.

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Nguồn‎: Anesthesiology 2013;118(1):40-50.

Mã bài‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Nguồn‎: J Am Heart Assoc 2015;4(6):e002066.

Mã bài‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST).

Ranucci M, Baryshnikova E.

Nguồn‎: Br J Anaesth 2016;116(5):618-23.

Mã bài‎: PubMed 26893405

DOI‎: 10.1093/bja/aev539

https://www.ncbi.nlm.nih.gov/pubmed/26893405

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate.

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Nguồn‎: Can J Anaesth 2012;59(3):299-303.

Mã bài‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243

Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa.

Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA.

Nguồn‎: Anesth Analg 2007;104(4):763-5.

Mã bài‎: PubMed 17377078

DOI‎: 10.1213/01.ane.0000250913.45299.f3

https://www.ncbi.nlm.nih.gov/pubmed/17377078

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products.

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

Nguồn‎: Scand J Clin Lab Invest 2012;72(2):121-8.

Mã bài‎: PubMed 22233480

DOI‎: 10.3109/00365513.2011.643818

https://www.ncbi.nlm.nih.gov/pubmed/22233480

Thuốc Desmopressin

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry.

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

Nguồn‎: Anaesthesia 2010;65(7):688-91.

Mã bài‎: PubMed 20477783

DOI‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy.

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Nguồn‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Mã bài‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065

Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults.

Wademan BH, Galvin SD.

Nguồn‎: Interact Cardiovasc Thorac Surg 2014;18(3):360-70.

Mã bài‎: PubMed 24263581

DOI‎: 10.1093/icvts/ivt491

https://www.ncbi.nlm.nih.gov/pubmed/24263581

A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery.

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C.

Nguồn‎: Anesth Analg 2010;110(3):702-7.

Mã bài‎: PubMed 20042444

DOI‎: 10.1213/ANE.0b013e3181c92a5c

https://www.ncbi.nlm.nih.gov/pubmed/20042444

Chất cầm máu đắp lên vết thương

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use.

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Nguồn‎: Ann Surg 2010;251(2):217-28.

Mã bài‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084

A review of topical hemostatic agents for use in cardiac surgery.

Barnard J, Millner R.

Nguồn‎: Ann Thorac Surg 2009;88(4):1377-83.

Mã bài‎: PubMed 19766855

DOI‎: 10.1016/j.athoracsur.2009.02.092

https://www.ncbi.nlm.nih.gov/pubmed/19766855

Armentarium of topical hemostatic products in cardiovascular surgery: an update.

Forcillo J, Perrault LP.

Nguồn‎: Transfus Apher Sci 2014;50(1):26-31.

Mã bài‎: PubMed 24412443

DOI‎: 10.1016/j.transci.2013.12.009

https://www.ncbi.nlm.nih.gov/pubmed/24412443

A novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses.

Mani K, Campbell A, Fitzpatrick J, Modarai B, Carrell T, Rashid H, Zayed H.

Nguồn‎: Eur J Vasc Endovasc Surg 2013;45(1):51-6.

Mã bài‎: PubMed 23134676

DOI‎: 10.1016/j.ejvs.2012.10.008

https://www.ncbi.nlm.nih.gov/pubmed/23134676

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Nguồn‎: Innovations (Phila) 2012;7(4):229-41.

Mã bài‎: PubMed 23123988

DOI‎: 10.1097/IMI.0b013e3182747699

https://www.ncbi.nlm.nih.gov/pubmed/23123988

Control of troublesome bleeding during repair of acute type A dissection with use of modified rapid deployment hemostat (MRDH).

Salerno TA, Gaughan C, Suarez M, Panos AL.

Nguồn‎: J Card Surg 2009;24(6):722-4.

Mã bài‎: PubMed 20078720

DOI‎: 10.1111/j.1540-8191.2009.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/20078720

Topical haemostatic agents.

Seyednejad H, Imani M, Jamieson T, Seifalian AM.

Nguồn‎: Br J Surg 2008;95(10):1197-225.

Mã bài‎: PubMed 18763249

DOI‎: 10.1002/bjs.6357

https://www.ncbi.nlm.nih.gov/pubmed/18763249

Các xét nghiệm chất nhầy để xác định chảy máu do phẫu thuật hay do chức năng đông máu

An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit.

Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W.

Nguồn‎: Transfus Med 2006;16(1):31-9.

Mã bài‎: PubMed 16480437

DOI‎: 10.1111/j.1365-3148.2006.00645.x

https://www.ncbi.nlm.nih.gov/pubmed/16480437

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Nguồn‎: Anesthesiology 2011;115(6):1179-91.

Mã bài‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887

Management of hemorrhage in cardiothoracic surgery.

Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA.

Nguồn‎: J Cardiothorac Vasc Anesth 2013;27(4 Suppl):S20-34.

Mã bài‎: PubMed 23910533

DOI‎: 10.1053/j.jvca.2013.05.014

https://www.ncbi.nlm.nih.gov/pubmed/23910533

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients.

Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K.

Nguồn‎: Anesthesiology 2012;117(3):531-47.

Mã bài‎: PubMed 22914710

DOI‎: 10.1097/ALN.0b013e318264c644

https://www.ncbi.nlm.nih.gov/pubmed/22914710


Phần y khoa của trang web jw.org được thiết kế nhằm cung cấp tài liệu chủ yếu cho bác sĩ và những người thuộc ngành y. Phần này không tư vấn về y khoa hoặc đề nghị bất cứ phương pháp điều trị nào, và cũng không thay thế cho bác sĩ. Tài liệu y khoa được liệt kê trong phần này không do Nhân Chứng Giê-hô-va xuất bản, nhưng bàn về những phương pháp điều trị không truyền máu mà bác sĩ có thể quyết định xem xét. Chính bác sĩ có trách nhiệm phân loại những thông tin cập nhật hơn, bàn bạc các phương cách điều trị và hỗ trợ bệnh nhân lựa chọn một cách sáng suốt dựa trên tình trạng sức khỏe, ước nguyện và niềm tin của bệnh nhân. Không phải tất cả các phương pháp được liệt kê đều thích hợp cho mọi bệnh nhân.

Đôi lời với bệnh nhân: Xin luôn hỏi ý kiến của bác sĩ về vấn đề sức khỏe và cách điều trị. Cần đi khám bác sĩ nếu cảm thấy bệnh.

Việc sử dụng trang web này được chi phối bởi các điều khoản sử dụng.